Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 278Carcinoma, Non-Small-Cell Lung 228Prostatic Neoplasms 183Neoplasms 180Multiple Myeloma 140Lung Neoplasms 137Neoplasm Metastasis 104Colorectal Neoplasms 101Melanoma 87Ovarian Neoplasms 86Leukemia, Myeloid, Acute 78Pancreatic Neoplasms 73Lymphoma 72Leukemia, Lymphocytic, Chronic, B-Cell 67Carcinoma, Renal Cell 65Squamous Cell Carcinoma of Head and Neck 64Lymphoma, Non-Hodgkin 64Brain Neoplasms 64Recurrence 57Urinary Bladder Neoplasms 56Carcinoma, Hepatocellular 56Hematologic Neoplasms 55Head and Neck Neoplasms 55Triple Negative Breast Neoplasms 52Lymphoma, Follicular 49Glioblastoma 49Endometrial Neoplasms 48Uterine Cervical Neoplasms 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 47Sarcoma 44

Interventions

Nivolumab 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Adenocarcinoma, Clear Cell × 90 days × Clear all
NCT03355976 2026-04-02

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Brown University

Phase 2 Active not recruiting
46 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence, Adenocarcinoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡